Hypoglycemia and jaundice in newborns with pituitary stalk interruption syndrome

Qi Wang1, Xiangji Meng2, Yan Sun1

  • 1Department of Paediatrics, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan.

Medicine
|June 9, 2021
PubMed

Insights

Neonatal Pituitary stalk interruption syndrome (PSIS) presents with hypoglycemia and jaundice, not dwarfism. Early diagnosis and hormone therapy are crucial for a good prognosis in affected newborns.

Area of Science:

  • Pediatric Endocrinology
  • Rare Diseases
  • Neonatal Medicine

Background:

  • Pituitary stalk interruption syndrome (PSIS) is a rare condition often associated with growth hormone deficiency.
  • Neonatal PSIS is exceptionally rare and challenging to diagnose due to the absence of typical short stature.
  • Undiagnosed neonatal PSIS can be life-threatening.

Purpose of the Study:

  • To identify and characterize neonatal PSIS cases.
  • To improve early diagnosis of neonatal PSIS.
  • To outline clinical features and treatment outcomes.

Main Methods:

  • Retrospective analysis of three neonatal PSIS patients treated between January 2017 and July 2020.
  • Collection of clinical data, endocrine hormone levels, and pituitary MRI findings.
  • Assessment of response to hormone replacement therapy and follow-up.

Main Results:

  • Three neonatal patients with PSIS were identified.
  • Key features included hypoglycemia, jaundice, combined pituitary hormone deficiency (CPHD) with micropenis and hypothyroidism.
  • Genetic causes were difficult to determine.
  • All patients responded well to hormone therapy, with follow-up up to 3 years.

Conclusions:

  • Persistent hypoglycemia and jaundice in newborns can indicate PSIS.
  • Early recognition and intervention are vital for preventing life-threatening complications.
  • Hormone replacement therapy ensures a positive prognosis for neonatal PSIS.

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
496
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
430
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.4K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.6K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.1K